Garda Capital Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Garda Capital Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,265	Closed	-$1.02M	–	513
2025 Q2	$1.02M	Sell	12,265 -10,287	-46%	-$821K	0.02%	374
2025 Q1	$1.83M	Buy	22,552 +8,176	+57%	+$731K	0.05%	339
2024 Q4	$1.29M	Buy	+14,376	New	+$1.39M	0.09%	141
2023 Q4	–	Sell	-68,410	Closed	-$5M	–	706
2023 Q3	$5M	Buy	+68,410	New	+$5.46M	0.23%	78
2023 Q2	–	Sell	-30,560	Closed	-$2.33M	–	492
2023 Q1	$2.33M	Buy	+30,560	New	+$2.54M	0.11%	143

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Garda Capital Partners's XBI Position: Q3 2025 in Review

Garda Capital Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 12,265 shares — an estimated $1.02M sold.

Garda Capital Partners first reported a position in XBI in Q1 2023 and held it in 5 quarters. The position peaked at $5M in Q3 2023. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Garda Capital Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
Garda Capital Partners sold 12,265 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $1.02M.
Garda Capital Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 5 quarters.
Garda Capital Partners's State Street SPDR S&P Biotech ETF position peaked at $5M in Q3 2023.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Garda Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.